Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

The drug joins abemaciclib (Verzenio) as approved CDK4/6 inhibitors in this setting, but the broader indication for ...

Regulatory reviews for ribociclib among patients with early breast cancer are continuously ongoing to include the EMA and China. 1. FDA approves Kisqali with an aromatase inhibitor and Kisqali Femara ...

The team found adding ribociclib, a drug that belongs to a class of CDK4/6 inhibitors, to standard hormone therapy not only ...

A new Fortnite Starter Pack has now been launched, and this one is called the Sun and Scales pack, providing players a useful amount of virtual currency as well as a selection of exclusive ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It targets high-risk HR-positive, HER2-negative stage II and III patients ...

Basel, September 17, 2024 – Novartis today announced that the US Food and Drug Administration (FDA) has approved Kisqali ® (ribociclib) in combination with an aromatase inhibitor (AI ...

Read the Medication Guide provided by your pharmacist before you start taking siponimod and each time you get a refill. If you have any questions, ask your doctor or pharmacist. Take this ...

Here are five questions to ask yourself when you are shopping for a starter home. Buying your first home can be daunting from an emotional and financial perspective. Experts suggest you remain in ...